Headline: Boston Scientific Reports Q4 2025 Earnings, Confirms Conference Call at 8:00 AM ET - BSX

[Para 1: The Lead] Boston Scientific (BSX) reported Q4 2025 earnings of $2.50 per share, surpassing analysts' estimates of $2.35, reflecting strong performance in its medical device and diagnostics segments. The company's total revenue stood at $3.2 billion, up 5% year-over-year. The earnings call is scheduled for 8:00 AM ET today, providing investors with an update on its strategic initiatives and market outlook. [Para 2-3: Supporting details & Context] Boston Scientific confirmed a 6% increase in its medical device segment revenue, driven by robust sales in cardiology and neurology. Diagnostics revenue climbed 7%, buoyed by the launch of its latest diagnostic platform. The company reiterated its 2026 financial guidance, anticipating a 4-6% revenue growth and a net income per share of $2.80 to $2.90. The call will feature CEO Michael T. Bhatia, who will discuss the company's pipeline and upcoming regulatory milestones.]